Alix Bullman graduated from the Université Libre de Bruxelles with a degree in European Studies and is a successful public affairs consultant. Alix joined the European Alliance for Access to Safe Medicines (EAASM) in January 2021. The EAASM, established in 2007, is a non-profit, independent, pan-European organisation which represents a multi-sectorial coalition of organisations dedicated to protecting patient safety.
Alix’s work involves raising awareness around the subject of medication errors and how traceability systems can greatly enhance patient safety. Her role includes co-ordinating the European Collaborative Action on Medication Errors and Traceability (ECAMET) Alliance, formed in 2020 it now comprises twenty-one health professional and healthcare stakeholder organisations. Since then, a comprehensive Pan-European survey and a call-to-action white paper has been produced. Critical to this project’s success will be a recognition within the new pharmaceutical legislation of the need for greater digitalisation and thus traceability systems to reduce medication errors. Alix is currently working on supporting the WHO campaign around the Global Patient Safety Day 2022 scheduled in September 2022, whose theme focuses on medication safety – under the slogan “Medication Without Harm”.
In addition, Alix has been working in the field of nanomedicines and follow-on nanosimilars. As patient safety issues have been recorded with certain follow-on medicines, this important patient safety project entails campaigning for a fit for purpose regulatory system which calls for the establishment of a European centralized procedure.